Table 1.
Mice | Zebrafish embryos | |
General | ||
Degree of conservation compared with humans | Mammalian | Vertebrate |
Optical clarity | − | + |
In vivo image resolution | Cellular | Molecular |
Cost to maintain | High | Low |
Generation time | 3 months | 3–6 months |
Number of animals used for each experiment | Small | Large |
Fully sequenced genome | + | + |
Developmental stage | Various | Embryonic |
Inbred strains | + | − |
Genome duplication | − | + |
Leukocytes | ||
Accurate model of human hematopoiesis | + | + |
Well-characterized immune system | + | +/− |
Conserved innate immune system | + | + |
Presence of adaptive immunity | + | − |
Suitable model for leukocyte random motility | − | + |
Suitable model for leukocyte transmigration | + | + |
Suitable model for leukocyte interstitial migration | +/− | + |
Tools | ||
Use of MO for transient gene depletion | − | + |
Reverse genetics | Knock-out, knock-in, tissue-specific knockout, inducible system | TALENs, ZFNs, knock-in, tissue-specific knockdown, inducible system |
Forward genetics | + | +/gynogenetic diploid screen |
Large-scale WISH screens | +/− | + |
In vivo chemical screens | − | + |
Administration of blocking antibodies | i.v. | Limited antibodies available |
TALENs, TAL effector nucleases; WISH, whole-mount in situ hybridization; ZFN, zinc-finger nucleases; i.v., intravenous; +, yes; −, no.